NextCure Depreciation & Amortization Growth & History (NXTC)

NextCure's depreciation and amortization was $2.2M for fiscal 2025.

View full NextCure company overview

NextCure annual depreciation and amortization history

NextCure annual depreciation and amortization

Fiscal yearPeriod endedDepreciation and amortizationChangeGrowth
20252025-12-31$2.2M−$700,000−24.14%
20242024-12-31$2.9M−$800,000−21.62%
20232023-12-31$3.7M−$400,000−9.76%
20222022-12-31$4.1M−$200,000−4.65%
20212021-12-31$4.3M$900,000+26.47%
20202020-12-31$3.4M$712,000+26.49%
20192019-12-31$2.7M$1.0M+60.29%
20182018-12-31$1.7M

NextCure depreciation and amortization trends

Over the last five fiscal years, NextCure's depreciation and amortization decreased from $3.4M to $2.2M, a change of −$1.2M. The latest reported quarter, Q2 2026, shows $272,000.

About the metric

What depreciation and amortization mean

Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.

Calculation and source

Reported depreciation and amortization

TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review NextCure source filings ↗

Community posts

It’s quiet here.

No posts about NXTC yet. Start the conversation.

Write the first post